UNICHEM LABORATORIES
Back to Income Statement
|
UNICHEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,785 Cr | ₹134,302 Cr | ₹1,270 Cr | ₹1,235 Cr | ₹1,104 Cr |
What is the latest Revenue of UNICHEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,785 Cr |
| Mar2024 | ₹134,302 Cr |
| Mar2023 | ₹1,270 Cr |
| Mar2022 | ₹1,235 Cr |
| Mar2021 | ₹1,104 Cr |
How is Revenue of UNICHEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,785 Cr | -98.67 | |
| Mar2024 | ₹134,302 Cr | 10,476.38 | |
| Mar2023 | ₹1,270 Cr | 2.81 | |
| Mar2022 | ₹1,235 Cr | 11.91 | |
| Mar2021 | ₹1,104 Cr | - | |
Compare Revenue of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,335.9 Cr | 9.5% | 38.2% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 9.5% |
38.2% |
-21.7% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses